Gene Expression, Meditative Movement, and Emotional Distress (GME)

Plain-language summary

This study examines the effect of a meditative movement practice on gene expression and emotional distress in women with a history of breast cancer. It enrolled post-menopausal women aged 45 and older who were diagnosed with stage 0-III breast cancer and had completed their primary treatment between 6 months and 5 years earlier. It was a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Arizona State University

Intervention

Meditative Movement

Start date

7/17/2017

Estimated completion

9/15/2020

Countries

United States

Related genes

Locations

• Pomona, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Female patients diagnosed with breast cancer, Stage 0- III
* Between 6 months and 5 years past primary treatment
* 45 years of age and older
* Post-menopausal
* Speak or understand English

Exclusion Criteria:

* Women who are unable to stand (e.g., wheelchair or walker bound)
* Patients who are too weak or ill
* Women on antibiotics.
* Working night shift
* Anemia
* Uncontrolled diabetes